Surgery Websites
Department of Surgery »  Faculty »  Vascular Surgery »  Warren J. Gasper, M.D.
Warren J. Gasper, M.D.

Warren J. Gasper, M.D.

Associate Professor of Surgery
Division of Vascular and Endovascular Surgery
Acting Chief, Section of Vascular Surgery,
San Francisco VA Medical Center
Director, Vascular Integrated Physiology and
Experimental Therapeutics (ViperX)

Contact Information

Division of Vascular & Endovascular Surgery
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
Warren.Gasper@ucsf.edu
Open Popup
  • 1995-99, Bowdoin College, A.B., Biochemistry and German
  • 1999-03, University of Maryland, M.D., Medicine
  • 2003-04, University of California, San Francisco, Intern, Surgery
  • 2004-05, University of California, San Francisco, Resident, Surgery
  • 2009-10, University of California, San Francisco, Chief Resident, Surgery
  • 2010-11, University of California, San Francisco, Fellow, Vascular Surgery Research
  • 2011-13, University of California, San Francisco, Fellow, Vascular Surgery

Dr. Warren J. Gasper received his medical degree at the University of Maryland. He then completed a general surgery residency and vascular surgery fellowship at the University of California San Francisco. Following residency, he completed a one year research fellowship in vascular physiology and translational research at the University of California San Francisco.

Lim/Thomas Excellence in Teaching Award
UCSF Department of Surgery Chief Residents
2018
Excellence in Teaching Award
UCSF Haile T. Debas Academy of Medical Educators
2017
First place, Poster Competition
Society for Vascular Surgery Annual Meeting
2011

Dr. Gasper's clinical interests include diseases of the aorta and its major branches, aneurysms and peripheral artery disease. Dr Gasper's research has been focused on translational projects involving vascular physiology and venous remodeling after arteriovenous fistula and lower extremity bypass surgeries. He also been active in research involving pharmacologic therapies to reduce or prevent restenosis and has been involved in pre-clinical studies as well as clinical trials using a novel endovascular approach to deliver therapy to the artery adventitia.

Data provided by UCSF Profiles, powered by CTSI
  • Transfusion Trigger after Operations in High Cardiac Risk Patients
    Sponsor:
    Sponsor ID:
    Funding Period:
    Oct 2017
    -
    Feb 2022
    Co-local Site Investigator
  • Targeted Endovascular Treatment of Inflammation for Vascular Healing in Humans
    Sponsor:
    Sponsor ID:
    Funding Period:
    Aug 2015
    -
    Apr 2020
    Co-Investigator
  • Imaging Substudy, part of "A Phase 2 Study for the Evaluation of Safety and Efficacy of Humacyte's Human Acellular Vessel for Use as a Vascular Prosthesis for Femoro-Popliteal Bypass in Patients With Peripheral Arterial Disease"
    Sponsor:
    Sponsor ID:
    Funding Period:
    Jun 2016
    -
    Mar 2020
    Principal Investigator
  • Randomized, Multicenter, Controlled Trial to Compare Best Endovascular versus Best Surgical Therapy in Patients With Critical Limb Ischemia (BEST-CLI)
    Sponsor:
    Sponsor ID:
    Funding Period:
    Dec 2014
    -
    Dec 2019
    Principal Investigator
Data provided by UCSF Profiles, powered by CTSI
MOST RECENT PUBLICATIONS FROM A TOTAL OF 64
Data provided by UCSF Profiles, powered by CTSI
  1. Ramirez JL, Zarkowsky DS, Boitano LT, Conrad MF, Arya S, Gasper WJ, Conte MS, Iannuzzi JC. A Novel Preoperative Risk Score for Non-Home Discharge After Elective Thoracic Endovascular Aortic Repair. J Vasc Surg. 2020 Oct 13. View in PubMed
  2. Lancaster EM, Wu B, Iannuzzi J, Oskowitz A, Gasper W, Vartanian S, Wick E, Hiramoto J, Eichler C, Lobo E, Reyzelman A, Reilly L, Sosa JA, Conte MS. Impact of the COVID-19 pandemic on an academic vascular practice and a multi-disciplinary limb preservation program. J Vasc Surg. 2020 Sep 12. View in PubMed
  3. Smith EJT, Ramirez JL, Wu B, Zarkowsky DS, Gasper WJ, Finlayson E, Conte MS, Iannuzzi JC. Living in a Food Desert is Associated with 30-day Readmission after Revascularization for Chronic Limb-Threatening Ischemia. Ann Vasc Surg. 2020 Jul 03. View in PubMed
  4. Wu B, Lancaster EM, Ramirez JL, Zarkowsky DS, Reyzelman AM, Gasper WJ, Conte MS, Hiramoto JS. Increased Reintervention After Infrainguinal Revascularization for Chronic Limb-Threatening Ischemia in Women. Ann Vasc Surg. 2020 Jun 17. View in PubMed
  5. Ramirez JL, Gasper WJ, Seib CD, Finlayson E, Conte MS, Sosa JA, Iannuzzi JC. Patient complexity by surgical specialty does not correlate with work relative value units. Surgery. 2020 Sep; 168(3):371-378. View in PubMed
  6. View All Publications

 

Site Directory
    X